Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The goal of this survey is to investigate the participants' preference for a specific screening/diagnostic tool to detect and assess gastro-esophageal cancer.
The main question it aims to answer are:
Participants will be asked to complete a survey of 20-25min, including a brief intake regarding their socio-economic status. This approach will allow us to correct for confounding factors.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Survey participants | Experimental | Participants who will complete a survey investigating their preference for diagnosis and assessment of gastro-esophageal cancer |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Survey | Other | Discrete choice survey |
|
| Measure | Description | Time Frame |
|---|---|---|
| The rate of contribution of diagnostic features to the preference of participants | A part-worth analysis, expressed as percentage, from a discrete choice experiment (questionnaire) will assess the features that are most important to the participants | 2 years |
| The percentage differences in preference of participants between geographical regions | Differences in preferences will be compared between different geographical regions using chi-squared or McNemar's test | 2 years |
| Measure | Description | Time Frame |
|---|---|---|
| Assess the rate patient-level demographics influence the importance of a test feature, expressed as an odds ratio | Assess the influence of demographic characteristics on the decision-making process using a multivariable logistic regression model, providing odds ratios. | 2 years |
| Assess the rate of trade-off demonstrated as odds ratio between cancer-related mortality reduction and costs |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Stijn Vanstraelen, MD | Contact | 16346822 | 0032 | stijn.vanstraelen@kuleuven.be |
| Name | Affiliation | Role |
|---|---|---|
| Stijn Vanstraelen, MD | UZ Leuven | Principal Investigator |
| Philippe Nafteux, MD, PhD | UZ Leuven | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University Hospitals Leuven | Recruiting | Leuven | 3000 | Belgium |
Data will be made available upon reasonable request with the principal investigator
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D004938 | Esophageal Neoplasms |
| D013274 | Stomach Neoplasms |
| ID | Term |
|---|---|
| D005770 | Gastrointestinal Neoplasms |
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
Not provided
Not provided
| ID | Term |
|---|---|
| D011795 | Surveys and Questionnaires |
| ID | Term |
|---|---|
| D003625 | Data Collection |
| D004812 | Epidemiologic Methods |
| D008919 | Investigative Techniques |
| D017531 | Health Care Evaluation Mechanisms |
Not provided
Not provided
A survey will be conducted in a single group of participants from different geographical regions and backgrounds
Not provided
Not provided
Not provided
Not provided
Based on an anticipated cancer detection and cost, we will assess the willingness-to-pay using a multivariable logistic regression, providing odds ratios. |
| 2 years |
| D006258 |
| Head and Neck Neoplasms |
| D004066 | Digestive System Diseases |
| D004935 | Esophageal Diseases |
| D005767 | Gastrointestinal Diseases |
| D013272 | Stomach Diseases |
| D011787 | Quality of Health Care |
| D017530 | Health Care Quality, Access, and Evaluation |
| D011634 | Public Health |
| D004778 | Environment and Public Health |